Featured-Reporter
-
Nobel laureate stresses need to develop biomarkers
After 40 years in basic science working with yeast cells, Nobel laureate Lee Hartwell, Ph.D., has turned his attention in a new direction. Read MoreApr 18, 2013
-
Therapy helps regenerate child’s undeveloped bones
Janelly Martinez-Amador was born with thin, fragile bones, and by 3, she had no visible bones on X-rays. Initially, doctors weren’t sure she would survive her first birthday. Read MoreApr 11, 2013
-
Moses receives AACR’s lifetime achievement in research award
Harold L. (Hal) Moses, M.D., professor of Medicine and Pathology, acting chair of Cancer Biology and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has received the 10th annual American Association for Cancer Research (AACR) Award for Lifetime Achievement in Cancer Research. Read MoreApr 11, 2013
-
New clinic links pediatric sarcoma treatment services
J. Carlton Smith noticed severe pain in his knee five years ago during a lacrosse tournament. Smith, then 13 years old, never imagined hearing the diagnosis doctors would give him: osteosarcoma, a cancer of the bone. Read MoreApr 11, 2013
-
Newborn screening program championed at VU helps save boy
John Isaac Stone Seabolt was born Feb. 26, less than two months after a new state law went into effect encouraging the screening of newborn babies for “silent” heart defects. Read MoreApr 11, 2013
-
Residents’ reduced hours don’t impact care, education
Restructuring work hours for first-year medical residents to accommodate a 2011 duty hour limit of no more than 16 shift hours substantially increases patient handovers, but doesn’t significantly affect efficiency and quality of care among medical inpatients, a Vanderbilt University Medical Center study has found. Read MoreApr 4, 2013
-
Community involvement aids translational research
As Carla Sevin, M.D., assistant professor of Medicine at Vanderbilt, began the process of writing a recent grant proposal, she was stumped. Read MoreApr 4, 2013
-
Vanderbilt researchers work to balance flu vaccine debate
Research in the last two years to examine the effectiveness of the influenza vaccine has raised public doubt about the flu shot's effectiveness. But two Vanderbilt researchers co-wrote an editorial in the Journal of the American Medical Association (JAMA) recently to help balance the current debate. Read MoreApr 4, 2013
-
VU’s Arteaga to lead American Association for Cancer Research
Carlos Arteaga, M.D., professor of Medicine and Cancer Biology at Vanderbilt, has been elected president-elect of the American Association for Cancer Research for 2013-2014. Read MoreApr 4, 2013
-
Steeplechase strengthens bond with Children’s Hospital
As the Iroquois Steeplechase gears up for its annual spring event, the race this year will honor one of the leaders at the Monroe Carell Jr. Children’s Hospital at Vanderbilt and also support a newly established fund for hospital research efforts. Read MoreMar 28, 2013
-
Infant mortality initiative’s achievements recognized
The recognition of three Vanderbilt-based leaders of the Tennessee Initiative for Perinatal Quality Care (TIPQC) caps off the collaboration’s highly successful first five years of work. Read MoreMar 28, 2013
-
Study finds high soy diet before lung cancer diagnosis improves survival
A new study by researchers at Vanderbilt University Medical Center and the Shanghai Cancer Institute found women who ate more soy food prior to a diagnosis of lung cancer lived longer than those who consumed less. The study, conducted in Shanghai, China, was published in the March 25 issue of the Journal of Clinical Oncology. Read MoreMar 26, 2013
-
Humanoid robot helps train children with autism
An interdisciplinary team of mechanical engineers and autism experts at Vanderbilt University have developed an adaptive robotic system and used it to demonstrate that humanoid robots can be powerful tools for enhancing the basic social learning skills of children with autism. Read MoreMar 23, 2013
-
Novel push-pull action clue to brain disorders
Researchers at Vanderbilt University have discovered a new “push-pull” mechanism in the brain that one day could lead to new treatments for movement disorders such as Parkinson’s disease, as well as stress-related disorders and addiction. Read MoreMar 21, 2013
-
Residency questions answered at Match Day
Match Day at Vanderbilt University School of Medicine (VUSM) has grown so popular the event moved from its traditional lecture hall setting at Light Hall to the more-spacious Langford Auditorium. Read MoreMar 21, 2013
-
Breast cancer study explores therapy to slow recurrence
Many patients with triple-negative breast cancer (TNBC) have recurrence of their disease after an initial response to chemotherapy because the cancer cells have become resistant to treatment. TNBC has a lower survival rate because of this pattern of resistance and there are no targeted agents to treat this form of breast cancer. Read MoreMar 21, 2013
-
Patient’s cancer journey inspires fund for research
There’s a long list of Vanderbilt faculty and staff who made an impact on Terri and Steve Voland when Steve was treated at Vanderbilt-Ingram Cancer Center for a rare type of cancer in his neck and spine. Read MoreMar 21, 2013
-
Balser outlines efforts to address shifting economy
An overview of financial pressures created by the federal budget sequester and other legislation now facing Vanderbilt University Medical Center and academic health centers across the country was presented March 12 at two leadership forums — the Spring Clinical Enterprise Leadership Assembly held that morning at Langford Auditorium, and a faculty meeting focused on impact on the research community the same afternoon in Light Hall. Read MoreMar 14, 2013
-
Recruitments bolster personalized medicine initiative
VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools. Read MoreMar 14, 2013
-
Heart failure therapy shows promise in early clinical trial
Vanderbilt University Medical Center and Acorda Therapeutics Inc. released findings from a Phase 1 clinical trial of glial growth factor 2 (GGF2) last week at the American College of Cardiology Annual Scientific Session in San Francisco. Read MoreMar 14, 2013